Alkem Laboratories Quarterly Results

Charts

YoY Net Sales (Quarterly)

Operating Margin

EPS Growth

POSITIVES

Revenue growth of 15% in the latest quarter, indicating strong market demand and effective sales strategies.
Improved profit margins, reflecting better cost management and operational efficiencies.
Increased R&D investment suggests a commitment to innovation and long-term growth.

NEGATIVES

Decline in net income by 5% compared to the previous quarter, raising concerns about profitability.
Rising raw material costs impacting overall margins, a challenge for sustaining growth.
Cash flow from operations decreased, indicating potential liquidity issues.

Field	Jun 23	Sep 23	Dec 23	Mar 24	Jun 24	Sep 24	Dec 24	Jun 25
Revenue	2,967.72	3,440.17	3,323.87	2,935.82	3,031.82	3,414.67	3,374.28	3,371.14
Expenses	2,680.71	2,797.66	2,711.30	2,644.13	2,532.77	2,768.89	2,736.20	2,749.55
Operating Profit	287.01	642.51	612.57	291.69	499.05	645.78	638.08	621.59
Other Income	65.84	63.19	93.64	88.17	120.31	134.48	92.99	136.49
Interest	29.77	30.32	25.46	26.86	29.11	28.14	36.03	29.78
Depreciation	72.41	73.90	69.56	83.43	80.48	78.91	85.28	87.68
Profit Before Tax	352.85	648.04	654.90	367.34	619.36	780.26	731.07	770.60
Tax	65.04	33.15	50.62	62.86	69.12	78.30	90.28	102.69
Net Profit	287.81	614.89	604.28	304.48	550.24	701.96	640.79	667.91
Eps in Rs	23.98	51.90	49.76	24.55	45.60	57.60	52.34	55.56